United States · FDA National Drug Code directory

MOUNJARO

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50090-8024_9a8571eb-fe53-48bc-ab4c-de929b625051
Product NDC
50090-8024
Form
INJECTION, SOLUTION
Composition / generic term
tirzepatide
Labeler
A-S Medication Solutions
Marketing category
NDA
Marketing start / end (source format)
20220513
Source listing expiry
20271231

Source-listed ingredients

  • TIRZEPATIDE — 5 mg/.5mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 4 SYRINGE in 1 CARTON (50090-8024-0) / .5 mL in 1 SYRINGE · 50090-8024-0

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →